Holen Sie sich die Stockscreener-App
11.54
4.53%
0.50
Handel nachbörslich:
11.54
Schlusskurs vom Vortag:
$11.04
Offen:
$11.25
24-Stunden-Volumen:
661.95K
Relative Volume:
2.35
Marktkapitalisierung:
$253.92M
Einnahmen:
$52.55M
Nettoeinkommen (Verlust:
$-23.69M
KGV:
-12.28
EPS:
-0.94
Netto-Cashflow:
$-15.29M
1W Leistung:
+5.29%
1M Leistung:
+18.48%
6M Leistung:
+150.87%
1J Leistung:
+327.41%
1-Tages-Spanne:
$11.06
$11.75
1-Wochen-Bereich:
$10.78
$11.75
52-Wochen-Spanne:
$2.38
$11.75
Exagen Inc Stock (XGN) Company Profile
Firmenname
Exagen Inc
Sektor
Branche
Telefon
(760) 560-1501
Adresse
1261 LIBERTY WAY, VISTA, CA
Vergleichen Sie XGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XGN
Exagen Inc
|
11.54 | 242.92M | 52.55M | -23.69M | -15.29M | -0.94 |
|
TMO
Thermo Fisher Scientific Inc
|
525.83 | 198.09B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
206.15 | 146.89B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
636.91 | 50.67B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
138.04 | 39.19B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
204.76 | 34.64B | 15.70B | 1.24B | 2.01B | 6.9036 |
Exagen Inc Stock (XGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-11 | Eingeleitet | B. Riley Securities | Buy |
| 2025-07-30 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-07-23 | Eingeleitet | Craig Hallum | Buy |
| 2022-08-05 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-04-15 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-10-08 | Eingeleitet | BTIG Research | Buy |
| 2020-06-02 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2019-10-14 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-10-14 | Eingeleitet | Cowen | Outperform |
| 2019-10-14 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Exagen Inc Aktie (XGN) Neueste Nachrichten
Exagen (XGN) Gets Maintained 'Overweight' Rating by Keybanc Anal - GuruFocus
Detecting support and resistance levels for Exagen Inc.Rate Hike & Low Drawdown Investment Strategies - newser.com
Has Exagen Inc. formed a bullish divergenceWeekly Loss Report & Reliable Price Breakout Alerts - newser.com
How to build a custom watchlist for Exagen Inc.Price Action & Safe Investment Capital Preservation Plans - newser.com
Will Exagen Inc. benefit from macro trendsQuarterly Portfolio Report & Weekly Setup with ROI Potential - newser.com
How Exagen Inc. stock compares to market leadersPortfolio Return Summary & Expert Approved Momentum Trade Ideas - newser.com
Will Exagen Inc. stock split attract more investorsEarnings Miss & Daily Volume Surge Trade Alerts - newser.com
Will Exagen Inc. stock recover faster than peersMarket Trend Report & Intraday High Probability Setup Alerts - newser.com
What to do if you’re stuck in Exagen Inc.Watch List & Verified Technical Trade Signals - newser.com
Should you hold or exit Exagen Inc. nowJuly 2025 Trade Ideas & Real-Time Volume Trigger Notifications - newser.com
Analyzing Exagen Inc. with multi timeframe chartsMarket Sentiment Summary & Smart Investment Allocation Tips - newser.com
Earnings visualization tools for Exagen Inc.Market Risk Analysis & High Return Stock Watch Alerts - newser.com
Custom strategy builders for tracking Exagen Inc.Trade Exit Summary & Daily Technical Stock Forecast Reports - newser.com
Will Exagen Inc. stock maintain momentum in 20252025 Market Sentiment & Safe Entry Zone Tips - newser.com
Is Exagen Inc. (E08A) stock testing key supportJuly 2025 Levels & Real-Time Chart Breakout Alerts - newser.com
Exagen’s (XGN) “Sell (D-)” Rating Reiterated at Weiss Ratings - Defense World
Is Exagen Inc. stock ready for a breakoutInflation Watch & Weekly Stock Breakout Alerts - newser.com
Does Exagen Inc. show high probability of reboundNew Guidance & Safe Entry Point Alerts - newser.com
Exagen (NASDAQ:XGN) Earns Sell (D-) Rating from Weiss Ratings - MarketBeat
What analysts say about Exagen Inc stockMoving Average Crossovers & Affordable Investment Tips - earlytimes.in
Can Exagen Inc. recover in the next quarterBond Market & Weekly Momentum Stock Picks - newser.com
Exagen Inc. (NASDAQ:XGN) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Exagen Inc. recovery potential after sell offBond Market & Reliable Price Breakout Signals - newser.com
Exagen Inc Stock Analysis and ForecastBullish Engulfing Patterns & Small Budget Capital Investment - earlytimes.in
Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates - MSN
Is Exagen Inc. stock a bargain at current levelsQuarterly Investment Review & Real-Time Volume Spike Alerts - newser.com
Will Exagen Inc. (E08A) stock recover faster than industryMarket Sentiment Review & Real-Time Volume Trigger Notifications - newser.com
Is Exagen Inc. (E08A) stock supported by free cash flowJuly 2025 Levels & Technical Buy Zone Confirmations - newser.com
What drives Exagen Inc stock priceUtilities Sector Analysis & Crush the Market with Breakout Winners - earlytimes.in
With 38% stake, Exagen Inc. (NASDAQ:XGN) seems to have captured institutional investors' interest - Yahoo Finance
Can Exagen Inc. (E08A) stock test all time highs2025 Growth vs Value & Reliable Breakout Forecasts - newser.com
Finanzdaten der Exagen Inc-Aktie (XGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Exagen Inc-Aktie (XGN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| NMSIC Co-Investment Fund, L.P. | 10% Owner |
Mar 25 '25 |
Sale |
3.30 |
350,000 |
1,155,000 |
1,758,958 |
| NMSIC Co-Investment Fund, L.P. | 10% Owner |
Nov 20 '24 |
Sale |
3.30 |
200,000 |
660,040 |
2,108,958 |
| Black Jeffrey G. | Chief Financial Officer |
Nov 15 '24 |
Buy |
2.98 |
22,298 |
66,448 |
274,492 |
| ABALLI JOHN | President and CEO |
Nov 14 '24 |
Buy |
2.81 |
24,305 |
68,297 |
689,799 |
0.95%
1.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):